royal osteoporosis society
royal osteoporosis society Company Information
Company Number
04995013
Website
http://theros.org.ukRegistered Address
st james house the square, lower bristol road, bath, BA2 3BH
Industry
Other human health activities
Telephone
01761473251
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
-0%
royal osteoporosis society Estimated Valuation
Pomanda estimates the enterprise value of ROYAL OSTEOPOROSIS SOCIETY at £1.9m based on a Turnover of £4.4m and 0.42x industry multiple (adjusted for size and gross margin).
royal osteoporosis society Estimated Valuation
Pomanda estimates the enterprise value of ROYAL OSTEOPOROSIS SOCIETY at £3.4m based on an EBITDA of £858.4k and a 3.9x industry multiple (adjusted for size and gross margin).
royal osteoporosis society Estimated Valuation
Pomanda estimates the enterprise value of ROYAL OSTEOPOROSIS SOCIETY at £12.3m based on Net Assets of £5.3m and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Royal Osteoporosis Society Overview
Royal Osteoporosis Society is a live company located in bath, BA2 3BH with a Companies House number of 04995013. It operates in the other human health activities sector, SIC Code 86900. Founded in December 2003, it's largest shareholder is unknown. Royal Osteoporosis Society is a mature, small sized company, Pomanda has estimated its turnover at £4.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Royal Osteoporosis Society Health Check
Pomanda's financial health check has awarded Royal Osteoporosis Society a 5 rating. We use a traffic light system to show it exceeds the industry average on 9 measures and has 2 areas for improvement. Company Health Check FAQs
9 Strong
1 Regular
2 Weak
Size
annual sales of £4.4m, make it larger than the average company (£841.8k)
£4.4m - Royal Osteoporosis Society
£841.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (4.7%)
- Royal Osteoporosis Society
4.7% - Industry AVG
Production
with a gross margin of 34.7%, this company has a comparable cost of product (34.7%)
34.7% - Royal Osteoporosis Society
34.7% - Industry AVG
Profitability
an operating margin of 15.8% make it more profitable than the average company (7.3%)
15.8% - Royal Osteoporosis Society
7.3% - Industry AVG
Employees
with 49 employees, this is above the industry average (20)
49 - Royal Osteoporosis Society
20 - Industry AVG
Pay Structure
on an average salary of £51.4k, the company has a higher pay structure (£24.6k)
£51.4k - Royal Osteoporosis Society
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £90k, this is more efficient (£48k)
£90k - Royal Osteoporosis Society
£48k - Industry AVG
Debtor Days
it gets paid by customers after 3 days, this is earlier than average (24 days)
3 days - Royal Osteoporosis Society
24 days - Industry AVG
Creditor Days
its suppliers are paid after 20 days, this is slower than average (16 days)
20 days - Royal Osteoporosis Society
16 days - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (9 days)
0 days - Royal Osteoporosis Society
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 207 weeks, this is more cash available to meet short term requirements (109 weeks)
207 weeks - Royal Osteoporosis Society
109 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 16%, this is a lower level of debt than the average (26.1%)
16% - Royal Osteoporosis Society
26.1% - Industry AVG
ROYAL OSTEOPOROSIS SOCIETY financials
Royal Osteoporosis Society's latest turnover from December 2022 is £4.4 million and the company has net assets of £5.3 million. According to their latest financial statements, Royal Osteoporosis Society has 49 employees and maintains cash reserves of £3.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4,409,507 | 4,288,882 | 5,075,668 | 4,454,324 | 4,566,017 | 4,367,906 | 4,841,209 | 4,801,456 | 4,921,634 | 3,369,471 | 3,469,416 | 3,237,182 | 3,528,691 | 4,227,808 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41,313 | 0 | 38,702 | 37,758 | 32,037 | 29,540 | 15,456 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 630,020 | 524,310 | 1,328,417 | -558,919 | -1,268,791 | -484,445 | -230,102 | 770,882 | 875,717 | 2,685 | 11,767 | -172,593 | -1,955,803 | -1,671,700 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 630,020 | 524,310 | 1,328,417 | -558,919 | -1,268,791 | -484,445 | -230,102 | 770,882 | 875,717 | 2,685 | 11,767 | -172,593 | -1,955,803 | -1,671,700 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52,788 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 630,020 | 524,310 | 1,328,417 | -558,919 | -1,268,791 | -484,445 | -230,102 | 718,094 | 875,717 | 2,685 | 11,767 | -172,593 | -1,955,803 | -1,671,700 |
| Employee Costs | 2,516,241 | 2,132,831 | 2,640,553 | 3,373,317 | 3,388,450 | 3,105,649 | 2,865,110 | 2,405,008 | 2,047,030 | 1,927,561 | 1,856,256 | 1,943,359 | 1,985,464 | 2,113,856 |
| Number Of Employees | 49 | 38 | 48 | 65 | 70 | 67 | 62 | 57 | 50 | 49 | 49 | 54 | 56 | 57 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 227,433 | 1,613,174 | 1,669,563 | 1,725,634 | 1,777,453 | 1,828,245 | 1,873,799 | 1,925,086 | 1,984,965 | 1,984,028 | 2,043,268 | 2,114,596 | 2,189,622 | 2,287,900 |
| Intangible Assets | 27,159 | 135,793 | 244,427 | 249,479 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 2,551,281 | 2,771,370 | 1,981,664 | 1,454,897 | 2,371,307 | 3,496,372 | 2,876,615 | 2,557,102 | 2,565,199 | 2,514,428 | 1,855,958 | 1,485,799 | 1,567,017 | 1,106,658 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2,805,873 | 4,520,337 | 3,895,654 | 3,430,010 | 4,148,760 | 5,324,617 | 4,750,414 | 4,482,188 | 4,550,164 | 4,498,456 | 3,899,226 | 3,600,395 | 3,756,639 | 3,394,558 |
| Stock & work in progress | 1,087 | 1,246 | 2,395 | 3,346 | 4,056 | 0 | 0 | 16,944 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 38,114 | 30,347 | 472,043 | 120,158 | 72,140 | 13,102 | 116,842 | 44,791 | 240,990 | 470,815 | 48,188 | 15,582 | 40,890 | 34,062 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 285,178 | 327,467 | 0 | 969,590 | 682,303 | 833,502 | 588,529 | 1,277,452 | 0 | 158,540 | 78,110 | 109,610 | 133,333 | 81,499 |
| Cash | 3,153,190 | 1,494,797 | 1,263,483 | 478,646 | 774,133 | 645,096 | 1,865,837 | 1,708,115 | 2,283,355 | 823,389 | 1,859,047 | 2,117,342 | 1,262,164 | 1,561,923 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 9,543 | 16,606 | 0 | 0 | 0 | 0 | 0 | 1,575,155 | 2,622,693 |
| total current assets | 3,477,569 | 1,853,857 | 1,737,921 | 1,571,740 | 1,532,632 | 1,501,243 | 2,587,814 | 3,047,302 | 2,524,345 | 1,452,744 | 1,985,345 | 2,242,534 | 3,011,542 | 4,300,177 |
| total assets | 6,283,442 | 6,374,194 | 5,633,575 | 5,001,750 | 5,681,392 | 6,825,860 | 7,338,228 | 7,529,490 | 7,074,509 | 5,951,200 | 5,884,571 | 5,842,929 | 6,768,181 | 7,694,735 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 158,046 | 102,960 | 515,349 | 185,474 | 274,446 | 145,996 | 173,063 | 113,002 | 191,203 | 112,277 | 64,847 | 80,234 | 198,348 | 259,454 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 633,429 | 455,665 | 0 | 444,302 | 476,053 | 302,699 | 419,492 | 686,665 | 939,813 | 839,091 | 1,005,370 | 1,095,960 | 1,663,059 | 683,353 |
| total current liabilities | 791,475 | 558,625 | 515,349 | 629,776 | 750,499 | 448,695 | 592,555 | 799,667 | 1,131,016 | 951,368 | 1,070,217 | 1,176,194 | 1,861,407 | 942,807 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 213,005 | 187,003 | 13,970 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 213,005 | 187,003 | 13,970 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 1,004,480 | 745,628 | 529,319 | 629,776 | 750,499 | 448,695 | 592,555 | 799,667 | 1,131,016 | 951,368 | 1,070,217 | 1,176,194 | 1,861,407 | 942,807 |
| net assets | 5,278,962 | 5,628,566 | 5,104,256 | 4,371,974 | 4,930,893 | 6,377,165 | 6,745,673 | 6,729,823 | 5,943,493 | 4,999,832 | 4,814,354 | 4,666,735 | 4,906,774 | 6,751,928 |
| total shareholders funds | 5,278,962 | 5,628,566 | 5,104,256 | 4,371,974 | 4,930,893 | 6,377,165 | 6,745,673 | 6,729,823 | 5,943,493 | 4,999,832 | 4,814,354 | 4,666,735 | 4,906,774 | 6,751,928 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 53,265 | 160,609 | 55,117 | 55,252 | 64,371 | 60,893 | 0 | 64,181 | 51,541 | 60,060 | 71,328 | 102,277 | 103,781 | 97,566 |
| Amortisation | 108,634 | 160,609 | 81,476 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | -159 | -1,149 | -951 | -710 | 4,056 | 0 | -16,944 | 16,944 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -34,522 | -114,229 | -617,705 | 335,305 | -92,161 | 141,233 | -616,872 | 1,081,253 | -388,365 | 503,057 | 1,106 | -49,031 | 58,662 | 115,561 |
| Creditors | 55,086 | -412,389 | 329,875 | -88,972 | 128,450 | -27,067 | 60,061 | -78,201 | 78,926 | 47,430 | -15,387 | -118,114 | -61,106 | 259,454 |
| Accruals and Deferred Income | 177,764 | 455,665 | -444,302 | -31,751 | 173,354 | -116,793 | -267,173 | -253,148 | 100,722 | -166,279 | -90,590 | -567,099 | 979,706 | 683,353 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 934,006 | -519,159 | -82,994 | 19,243 | -35,305 | -476,497 | -234,307 | -13,479 | -355,213 | -991,943 |
| Change in Investments | -220,089 | 789,706 | 526,767 | -916,410 | -1,125,065 | 619,757 | 319,513 | -8,097 | 50,771 | 658,470 | 370,159 | -81,218 | 460,359 | 1,106,658 |
| cash flow from investments | 220,089 | -789,706 | -526,767 | 916,410 | 2,059,071 | -1,138,916 | -402,507 | 27,340 | -86,076 | -1,134,967 | -604,466 | 67,739 | -815,572 | -2,098,601 |
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 26,002 | 173,033 | 13,970 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41,313 | 0 | -38,702 | -37,758 | -32,037 | -29,540 | -15,456 |
| cash flow from financing | -953,622 | 173,033 | -582,165 | 0 | -177,481 | 115,937 | 245,952 | 26,923 | 67,944 | 144,091 | 98,094 | -99,483 | 81,109 | 8,408,172 |
| cash and cash equivalents | ||||||||||||||
| cash | 1,658,393 | 231,314 | 784,837 | -295,487 | 129,037 | -1,220,741 | 157,722 | -575,240 | 1,459,966 | -1,035,658 | -258,295 | 855,178 | -299,759 | 1,561,923 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 1,658,393 | 231,314 | 784,837 | -295,487 | 129,037 | -1,220,741 | 157,722 | -575,240 | 1,459,966 | -1,035,658 | -258,295 | 855,178 | -299,759 | 1,561,923 |
royal osteoporosis society Credit Report and Business Information
Royal Osteoporosis Society Competitor Analysis
Perform a competitor analysis for royal osteoporosis society by selecting its closest rivals and benchmarking them against 12 key performance metrics.
royal osteoporosis society Ownership
ROYAL OSTEOPOROSIS SOCIETY group structure
Royal Osteoporosis Society has 1 subsidiary company.
Ultimate parent company
ROYAL OSTEOPOROSIS SOCIETY
04995013
1 subsidiary
royal osteoporosis society directors
Royal Osteoporosis Society currently has 14 directors. The longest serving directors include Dr Neil Gittoes (Jul 2015) and Mrs Frances Grigg (Jul 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Neil Gittoes | 58 years | Jul 2015 | - | Director | |
| Mrs Frances Grigg | England | 65 years | Jul 2015 | - | Director |
| Mr Richard Darch | England | 62 years | Feb 2019 | - | Director |
| Dr Rosemary Leonard | England | 67 years | May 2019 | - | Director |
| Dr Nicola Peel | England | 63 years | May 2019 | - | Director |
| Mr Peter Gotham | England | 72 years | Jul 2019 | - | Director |
| Ms Judith Lyons | 59 years | Jun 2022 | - | Director | |
| Mr Paul Herbert | England | 53 years | Jun 2022 | - | Director |
| Mrs Teresa Hicks | England | 43 years | Sep 2022 | - | Director |
| Mr Ian Cooper | 63 years | Sep 2022 | - | Director |
P&L
December 2022turnover
4.4m
+3%
operating profit
696.5k
0%
gross margin
34.8%
+8.18%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
5.3m
-0.06%
total assets
6.3m
-0.01%
cash
3.2m
+1.11%
net assets
Total assets minus all liabilities
Similar Companies
royal osteoporosis society company details
company number
04995013
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
December 2003
age
21
accounts
Group
ultimate parent company
previous names
national osteoporosis society (January 2019)
incorporated
UK
address
st james house the square, lower bristol road, bath, BA2 3BH
last accounts submitted
December 2022
royal osteoporosis society Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to royal osteoporosis society.
royal osteoporosis society Companies House Filings - See Documents
| date | description | view/download |
|---|
